hydroxyurea has been researched along with Cochlear Hearing Loss in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sex, age, foetal haemoglobin (HbF), SCD type, painful vaso-occlusive crisis (PVO), blood parameters, flow-mediated vasodilation (FMV), and hydroxyurea use were all extracted." | 5.41 | Scoping Review of Predisposing Factors Associated with Sensorineural Hearing Loss in Sickle Cell Disease. ( Dagwa, I; Dahilo, E; Ibekwe, P; Ibekwe, T; Nnebe-Agumadu, U; Nnodu, O; Ramma, L; Rogers, C, 2023) |
| "Sudden sensorineural hearing loss that presents as the initial sign of haematological disease is very rare." | 2.41 | Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome. ( Chae, SW; Cho, JH; Hwang, SJ; Kang, HJ; Lee, JH, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibekwe, T | 1 |
| Nnodu, O | 1 |
| Nnebe-Agumadu, U | 1 |
| Dagwa, I | 1 |
| Dahilo, E | 1 |
| Ibekwe, P | 1 |
| Rogers, C | 1 |
| Ramma, L | 1 |
| Sathornsumetee, S | 1 |
| DesJardins, A | 1 |
| Reardon, DA | 1 |
| Rich, JN | 1 |
| Vredenburgh, JJ | 1 |
| Genden, EM | 1 |
| Bahadori, RS | 1 |
| Chae, SW | 1 |
| Cho, JH | 1 |
| Lee, JH | 1 |
| Kang, HJ | 1 |
| Hwang, SJ | 1 |
2 reviews available for hydroxyurea and Cochlear Hearing Loss
| Article | Year |
|---|---|
Scoping Review of Predisposing Factors Associated with Sensorineural Hearing Loss in Sickle Cell Disease.
Topics: Anemia, Sickle Cell; Hearing Loss, Sensorineural; Humans; Hydroxyurea; Pain; Prospective Studies; Re | 2023 |
Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome.
Topics: Blood Viscosity; Cochlea; Combined Modality Therapy; Follow-Up Studies; Hearing Loss, Sensorineural; | 2002 |
2 other studies available for hydroxyurea and Cochlear Hearing Loss
| Article | Year |
|---|---|
Neurofibromatosis type 2.
Topics: Antineoplastic Agents; Benzamides; Cochlear Nerve; Female; Functional Laterality; Hearing Loss, Sens | 2007 |
Bilateral sensorineural hearing loss as a first symptom of chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Audiometry; Female; Follow-Up Studies; Hearing Loss, Bilateral; Hearing Loss, | 1995 |